Er:YAG Laser Therapy for Xanthelasma Palpebrarum: A Retrospective Case Series Evaluating Clinical Efficacy, Safety, and Patient Outcomes in Periocular Lesion Management
Xanthelasma palpebrarum (XP) is a benign condition of the eyelid skin, characterized by the appearance of well-defined, bilateral, yellow-colored papules or plaques in the periorbital area. Although patients often seek dermatological consultation for cosmetic reasons, the associated medical implicat...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Case Reports in Dermatological Medicine |
| Online Access: | http://dx.doi.org/10.1155/crdm/4616721 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850101117503930368 |
|---|---|
| author | Saman Al-Zahawi Sara Masoomi Ifa Etesami |
| author_facet | Saman Al-Zahawi Sara Masoomi Ifa Etesami |
| author_sort | Saman Al-Zahawi |
| collection | DOAJ |
| description | Xanthelasma palpebrarum (XP) is a benign condition of the eyelid skin, characterized by the appearance of well-defined, bilateral, yellow-colored papules or plaques in the periorbital area. Although patients often seek dermatological consultation for cosmetic reasons, the associated medical implications, especially in younger individuals, hold significant medical importance. XP can be treated through various methods such as surgical removal, trichloroacetic acid (TCA) 70% application, cryotherapy, and laser procedures. Among the laser therapies (CO2, pulsed dye laser, and Er:YAG), which have proven effective due to their convenient application and fewer complications, the Er:YAG laser stands out for its potential to deliver faster recovery, fewer pigmentation changes, minimal scarring, and a shorter period of postlaser redness. This study evaluated Er:YAG laser for XP in four cases. Three laser sessions effectively treated the lesions, leading to patient satisfaction despite incomplete clearance, with no recurrence in 12 months and no side effects. The study concluded that Er:YAG laser is preferred over other lasers for this condition due to its superior healing profile. |
| format | Article |
| id | doaj-art-8aa2eca57bdf4e5c8c7ea59b2c6e2171 |
| institution | DOAJ |
| issn | 2090-6471 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Dermatological Medicine |
| spelling | doaj-art-8aa2eca57bdf4e5c8c7ea59b2c6e21712025-08-20T02:40:07ZengWileyCase Reports in Dermatological Medicine2090-64712025-01-01202510.1155/crdm/4616721Er:YAG Laser Therapy for Xanthelasma Palpebrarum: A Retrospective Case Series Evaluating Clinical Efficacy, Safety, and Patient Outcomes in Periocular Lesion ManagementSaman Al-Zahawi0Sara Masoomi1Ifa Etesami2Department of Dermatology/Razi HospitalDepartment of Dermatology/Razi HospitalDepartment of Dermatology/Razi HospitalXanthelasma palpebrarum (XP) is a benign condition of the eyelid skin, characterized by the appearance of well-defined, bilateral, yellow-colored papules or plaques in the periorbital area. Although patients often seek dermatological consultation for cosmetic reasons, the associated medical implications, especially in younger individuals, hold significant medical importance. XP can be treated through various methods such as surgical removal, trichloroacetic acid (TCA) 70% application, cryotherapy, and laser procedures. Among the laser therapies (CO2, pulsed dye laser, and Er:YAG), which have proven effective due to their convenient application and fewer complications, the Er:YAG laser stands out for its potential to deliver faster recovery, fewer pigmentation changes, minimal scarring, and a shorter period of postlaser redness. This study evaluated Er:YAG laser for XP in four cases. Three laser sessions effectively treated the lesions, leading to patient satisfaction despite incomplete clearance, with no recurrence in 12 months and no side effects. The study concluded that Er:YAG laser is preferred over other lasers for this condition due to its superior healing profile.http://dx.doi.org/10.1155/crdm/4616721 |
| spellingShingle | Saman Al-Zahawi Sara Masoomi Ifa Etesami Er:YAG Laser Therapy for Xanthelasma Palpebrarum: A Retrospective Case Series Evaluating Clinical Efficacy, Safety, and Patient Outcomes in Periocular Lesion Management Case Reports in Dermatological Medicine |
| title | Er:YAG Laser Therapy for Xanthelasma Palpebrarum: A Retrospective Case Series Evaluating Clinical Efficacy, Safety, and Patient Outcomes in Periocular Lesion Management |
| title_full | Er:YAG Laser Therapy for Xanthelasma Palpebrarum: A Retrospective Case Series Evaluating Clinical Efficacy, Safety, and Patient Outcomes in Periocular Lesion Management |
| title_fullStr | Er:YAG Laser Therapy for Xanthelasma Palpebrarum: A Retrospective Case Series Evaluating Clinical Efficacy, Safety, and Patient Outcomes in Periocular Lesion Management |
| title_full_unstemmed | Er:YAG Laser Therapy for Xanthelasma Palpebrarum: A Retrospective Case Series Evaluating Clinical Efficacy, Safety, and Patient Outcomes in Periocular Lesion Management |
| title_short | Er:YAG Laser Therapy for Xanthelasma Palpebrarum: A Retrospective Case Series Evaluating Clinical Efficacy, Safety, and Patient Outcomes in Periocular Lesion Management |
| title_sort | er yag laser therapy for xanthelasma palpebrarum a retrospective case series evaluating clinical efficacy safety and patient outcomes in periocular lesion management |
| url | http://dx.doi.org/10.1155/crdm/4616721 |
| work_keys_str_mv | AT samanalzahawi eryaglasertherapyforxanthelasmapalpebrarumaretrospectivecaseseriesevaluatingclinicalefficacysafetyandpatientoutcomesinperiocularlesionmanagement AT saramasoomi eryaglasertherapyforxanthelasmapalpebrarumaretrospectivecaseseriesevaluatingclinicalefficacysafetyandpatientoutcomesinperiocularlesionmanagement AT ifaetesami eryaglasertherapyforxanthelasmapalpebrarumaretrospectivecaseseriesevaluatingclinicalefficacysafetyandpatientoutcomesinperiocularlesionmanagement |